These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
132 related items for PubMed ID: 22763962
41. The clinical values of squamous cell carcinoma antigen and carcinoembryonic antigen in patients with cervical cancer treated with concurrent chemoradiotherapy. Yoon SM, Shin KH, Kim JY, Seo SS, Park SY, Kang S, Cho KH. Int J Gynecol Cancer; 2007; 17(4):872-8. PubMed ID: 17343571 [Abstract] [Full Text] [Related]
42. Can serial evaluation of serum SCC-Ag-level predict tumor recurrence and patient survival in squamous-cell carcinoma of uterine cervix treated with definitive chemoradiotherapy? A multi-institutional analysis. Choi KH, Yu M, Jeong S, Lee JH. Int J Clin Oncol; 2020 Jul; 25(7):1405-1411. PubMed ID: 32221801 [Abstract] [Full Text] [Related]
43. An evaluation of p16(INK4a) expression in cervical intraepithelial neoplasia specimens, including women with HIV-1. Nicol AF, Golub JE, e Silva JR, Cunha CB, Amaro-Filho SM, Oliveira NS, Menezes W, Andrade CV, Russomano F, Tristão A, Grinsztejn B, Friedman RK, Oliveira MP, Pires A, Nuovo GJ. Mem Inst Oswaldo Cruz; 2012 Aug; 107(5):571-7. PubMed ID: 22850945 [Abstract] [Full Text] [Related]
44. Association between serum cytokines and progression of breast cancer in Chinese population. Wang H, Yang X. Medicine (Baltimore); 2017 Dec; 96(49):e8840. PubMed ID: 29245248 [Abstract] [Full Text] [Related]
45. Evaluation of chemotherapy response with serum squamous cell carcinoma antigen level in cervical cancer patients: a prospective cohort study. Yin M, Hou Y, Zhang T, Cui C, Zhou X, Sun F, Li H, Li X, Zheng J, Chen X, Li C, Ning X, Li K, Lou G. PLoS One; 2013 Dec; 8(1):e54969. PubMed ID: 23349993 [Abstract] [Full Text] [Related]
46. The curative role of radiotherapy in patients with isolated para-aortic node recurrence from cervical cancer and value of squamous cell carcinoma antigen for early detection. Ogino I, Nakayama H, Kitamura T, Okamoto N, Inoue T. Int J Gynecol Cancer; 2005 Dec; 15(4):630-8. PubMed ID: 16014117 [Abstract] [Full Text] [Related]
47. Study on serum miR-182 as a marker for diagnosis and prognosis of cervical cancer. Gao F, Wang Y, Li H, Yin J. Technol Health Care; 2024 Dec; 32(5):3083-3095. PubMed ID: 38848201 [Abstract] [Full Text] [Related]
48. Correlation Between Squamous Cell Carcinoma Antigen Level and the Clinicopathological Features of Early-Stage Cervical Squamous Cell Carcinoma and the Predictive Value of Squamous Cell Carcinoma Antigen Combined With Computed Tomography Scan for Lymph Node Metastasis. Xu D, Wang D, Wang S, Tian Y, Long Z, Ren X. Int J Gynecol Cancer; 2017 Nov; 27(9):1935-1942. PubMed ID: 28914639 [Abstract] [Full Text] [Related]
49. Elevated circulating tumor cells and squamous cell carcinoma antigen levels predict poor survival for patients with locally advanced cervical cancer treated with radiotherapy. Wen YF, Cheng TT, Chen XL, Huang WJ, Peng HH, Zhou TC, Lin XD, Zeng LS. PLoS One; 2018 Nov; 13(10):e0204334. PubMed ID: 30303986 [Abstract] [Full Text] [Related]
50. Role of the hematopoietic cytokines SCF, IL-3, GM-CSF and M-CSF in the diagnosis of pancreatic and ampullary cancer. Vasiliades G, Kopanakis N, Vasiloglou M, Zografos G, Margaris H, Masselou K, Kokosi E, Liakakos T. Int J Biol Markers; 2012 Oct 08; 27(3):e186-94. PubMed ID: 22865301 [Abstract] [Full Text] [Related]
51. Serum levels of angiogenin (ANG) in invasive cervical cancer and in cervical intraepithelial neoplasia (CIN). Bodner-Adler B, Hefler L, Bodner K, Leodolter S, Frischmuth K, Kainz C, Mayerhofer K. Anticancer Res; 2001 Oct 08; 21(1B):809-12. PubMed ID: 11299848 [Abstract] [Full Text] [Related]
53. Hematopoietic cytokines as tumor markers in gynecological malignancies. A multivariate analysis in epithelial ovarian cancer patients. Lawicki S, Gacuta-Szumarska E, Będkowska GE, Szmitkowski M. Growth Factors; 2012 Dec 08; 30(6):357-66. PubMed ID: 22988839 [Abstract] [Full Text] [Related]
54. Serum levels of stearic and dihomo-γ-linolenic acids can be used to diagnose cervical cancer and cervical intraepithelial neoplasia. Katoh Y, Kubo A, Hayashi N, Sugi T, Katoh K, Udagawa S, Ogawa T, Iwata T, Nishio H, Sugawara M, Hirai S, Kawana K. Sci Rep; 2024 Sep 06; 14(1):20833. PubMed ID: 39242718 [Abstract] [Full Text] [Related]
55. Prognostic value of tumor measurement parameters and SCC-Ag changes in patients with locally-advanced cervical cancer. Chen W, Xiu S, Xie X, Guo H, Xu Y, Bai P, Xia X. Radiat Oncol; 2022 Jan 10; 17(1):6. PubMed ID: 35012582 [Abstract] [Full Text] [Related]
56. Prognostic value of pre-treatment circulating monocyte count in patients with cervical cancer: comparison with SCC-Ag level. Lee YY, Choi CH, Sung CO, Do IG, Huh S, Song T, Kim MK, Kim HJ, Kim TJ, Lee JW, Kim BG, Bae DS. Gynecol Oncol; 2012 Jan 10; 124(1):92-7. PubMed ID: 22014631 [Abstract] [Full Text] [Related]
57. The Validity of Using Human Squamous Cell Carcinoma Associated Antigen and Cytokeratin 19 Fragment Antigen 21-1 to Predict Postoperative Adjuvant Radiotherapy for Nonbulky Early-Stage Squamous Cell Carcinoma of the Cervix. Liu CZ, Zeng HX, Zhao JJ, Rong Y, Mo ZL, Li LA, Zhang JQ. Int J Gynecol Cancer; 2017 Jun 10; 27(5):994-1000. PubMed ID: 28498239 [Abstract] [Full Text] [Related]